$27.81
0.32%
Nasdaq, Nov 21, 10:01 pm CET
ISIN
NL0010696654
Symbol
QURE

uniQure N.V. Stock price

$27.81
-35.26 55.91% 1M
+12.31 79.42% 6M
+10.15 57.47% YTD
+21.97 375.79% 1Y
+6.33 29.47% 3Y
-18.69 40.19% 5Y
+8.55 44.39% 10Y
+13.20 90.35% 20Y
Nasdaq, Closing price Fri, Nov 21 2025
-0.09 0.32%
ISIN
NL0010696654
Symbol
QURE
Industry

Key metrics

Basic
Market capitalization
$1.7b
Enterprise Value
$1.6b
Net debt
positive
Cash
$694.3m
Shares outstanding
62.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
110.0 | 94.3
EV/Sales
98.8 | 84.7
EV/FCF
negative
P/B
7.6
Financial Health
Equity Ratio
-1.2%
Return on Equity
3,547.9%
ROCE
-22.8%
ROIC
-130.3%
Debt/Equity
2.3
Financials (TTM | estimate)
Revenue
$15.8m | $18.4m
EBITDA
$-163.7m | $-155.0m
EBIT
$-179.9m | $-182.5m
Net Income
$-235.2m | $-214.9m
Free Cash Flow
$-153.6m
Growth (TTM | estimate)
Revenue
-44.9% | -32.3%
EBITDA
10.2% | 5.8%
EBIT
7.6% | -3.0%
Net Income
1.8% | 10.3%
Free Cash Flow
16.9%
Margin (TTM | estimate)
Gross
88.1%
EBITDA
-1,039.6% | -843.7%
EBIT
-1,142.1%
Net
-1,492.9% | -1,170.1%
Free Cash Flow
-975.2%
More
EPS
$-4.0
FCF per Share
$-2.5
Short interest
11.2%
Employees
209
Rev per Employee
$130.0k
Show more

Is uniQure N.V. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,052 stocks worldwide.

uniQure N.V. Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a uniQure N.V. forecast:

18x Buy
90%
2x Hold
10%

Analyst Opinions

20 Analysts have issued a uniQure N.V. forecast:

Buy
90%
Hold
10%

Financial data from uniQure N.V.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
16 16
45% 45%
100%
- Direct Costs 1.87 1.87
93% 93%
12%
14 14
580% 580%
88%
- Selling and Administrative Expenses 55 55
5% 5%
349%
- Research and Development Expense 140 140
7% 7%
887%
-164 -164
10% 10%
-1,040%
- Depreciation and Amortization 16 16
30% 30%
103%
EBIT (Operating Income) EBIT -180 -180
8% 8%
-1,142%
Net Profit -235 -235
2% 2%
-1,493%

In millions USD.

Don't miss a Thing! We will send you all news about uniQure N.V. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

uniQure N.V. Stock News

Neutral
PRNewsWire
2 days ago
RADNOR, Pa. , Nov. 22, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of uniQure N.V.
Neutral
Seeking Alpha
7 days ago
Though positive on an absolute basis, Diamond Hill International Strategy portfolio modestly trailed the benchmark during the quarter. From a sector perspective, health care and information technology contributed most to relative performance, while financials and industrials detracted on a relative basis. Geographically, international businesses that are classified as US stocks were the largest...
Neutral
GlobeNewsWire
10 days ago
RADNOR, Pa., Nov. 14, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of uniQure N.V. (NASDAQ: QURE) (“uniQure”).
More uniQure N.V. News

Company Profile

uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.

Head office Netherlands
CEO Matt Kapusta
Employees 209
Founded 2012
Website www.uniqure.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today